Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02553317
What this trial is testing

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
Ablynx, a Sanofi company 145
Large-scale testing (Phase 3)Not Yet RecruitingNCT06770426
What this trial is testing

CompARing Between CO2 Phenylephrine and Phenylephrine Only Treatment in Patients With proGrEssing Cerebral infarctioN

Who this might be right for
Acute Ischemic Stroke
Yonsei University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07019545
What this trial is testing

A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPY

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Hellenic Society of Hematology 14
Testing effectiveness (Phase 2)Study completedNCT00908037
What this trial is testing

Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 82
Not applicableStudy completedNCT07218536
What this trial is testing

The Burden of Atypical Hemolytic Uremic Syndrome and The Clinical Characteristics of Patients in Egyptian Hospitals A Multicenter, Observational, Retrospective Cohort Study in Egypt

Who this might be right for
Atypical Hemolytic Uremic Syndrome
AstraZeneca 200
Testing effectiveness (Phase 2)Study completedNCT00937131
What this trial is testing

The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
University College, London 40
Not applicableStudy completedNCT02344901
What this trial is testing

ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES)

Who this might be right for
Thrombotic StrokeAtrial Fibrillation and Flutter
Muğla Sıtkı Koçman University 6,273
Not applicableActive Not RecruitingNCT06099236
What this trial is testing

A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients

Who this might be right for
Atypical Hemolytic Uremic Syndrome(aHUS)
AstraZeneca 367
Not applicableNot Yet RecruitingNCT06790888
What this trial is testing

Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid Failure

Who this might be right for
ITP - Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 78
Not applicableUnknownNCT05296499
What this trial is testing

EXERT: Exercise Physiology After Thrombosis

Who this might be right for
Venous Thrombosis Deep (Limbs)Post Thrombotic Syndrome
Guy's and St Thomas' NHS Foundation Trust 56
Large-scale testing (Phase 3)Study completedNCT02504216
What this trial is testing

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Who this might be right for
Peripheral Artery Disease
Bayer 6,564
Not applicableStudy completedNCT04287881
What this trial is testing

Methylenetetrahydrofolate Reductase Deficiency in Ischemic Stroke

Who this might be right for
Hyperhomocysteinemia, Thrombotic, Cbs-RelatedIschemic StrokeEpilepsy
Istanbul Medeniyet University 32
Not applicableStudy completedNCT05263193
What this trial is testing

Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)

Who this might be right for
Immune-mediated Thrombocytopenic Purpura
Sanofi 4
Post-approval studies (Phase 4)Study completedNCT01432795
What this trial is testing

Practicability of Gliding Aids for Medical Compression Stockings

Who this might be right for
Chronic Venous InsufficiencyPost-thrombotic Syndrome
University of Zurich 40
Not applicableStudy completedNCT03050138
What this trial is testing

Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran

Who this might be right for
Postthrombotic Syndrome
Oslo University Hospital 351
Not applicableNot Yet RecruitingNCT07405749
What this trial is testing

Cirrhotic and Non-cirrhotic Patients With Clinically Significant Portal Hypertension

Who this might be right for
Cirrhosis, LiverPortal HypertensionClinically Significant Portal Hypertension(CSPH)+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2,500
Not applicableLooking for participantsNCT05931718
What this trial is testing

Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia

Who this might be right for
Autoimmune Hemolytic AnemiaImmune ThrombocytopeniaChronic Idiopathic Neutropenia+3 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 200
Not applicableStudy completedNCT00603148
What this trial is testing

The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications

Who this might be right for
Genetic Polymorphism
Vanderbilt University 475
Testing effectiveness (Phase 2)Study completedNCT00220727
What this trial is testing

Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Grifols Therapeutics LLC 8
Testing effectiveness (Phase 2)UnknownNCT05369377
What this trial is testing

Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 150
Next Page